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Abstract
The serine/threonine kinase Pim-1 directs selected signaling events that promote cell growth and survival and is
overexpressed in diverse human cancers. Pim-1 expression is tightly controlled through multiple mechanisms, including
regulation of mRNA turnover. In several cultured cell models, mitogenic stimulation rapidly induced and stabilized PIM1
mRNA, however, vigorous destabilization 4–6 hours later helped restore basal expression levels. Acceleration of PIM1 mRNA
turnover coincided with accumulation of tristetraprolin (TTP), an mRNA-destabilizing protein that targets transcripts
containing AU-rich elements. TTP binds PIM1 mRNA in cells, and suppresses its expression by accelerating mRNA decay.
Reporter mRNA decay assays localized the TTP-regulated mRNA decay element to a discrete AU-rich sequence in the distal
39-untranslated region that binds TTP. These data suggest that coordinated stimulation of TTP and PIM1 expression limits
the magnitude and duration of PIM1 mRNA accumulation by accelerating its degradation as TTP protein levels increase.
Consistent with this model, PIM1 and TTP mRNA levels were well correlated across selected human tissue panels, and PIM1
mRNA was induced to significantly higher levels in mitogen-stimulated fibroblasts from TTP-deficient mice. Together, these
data support a model whereby induction of TTP mediates a negative feedback circuit to limit expression of selected
mitogen-activated genes.
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Introduction
The PIM1 gene encodes a serine/threonine kinase that can
regulate cell proliferation and survival at multiple levels [1,2]. For
example, Pim-1-mediated phosphorylation of the tyrosine
phosphatase Cdc25A increases its activity [3], which includes
activation of Cdk2/cyclin E to promote progression from G1 into
S phase [4]. In response to genotoxic stress, the cyclin-dependent
kinase inhibitor p21
waf/Cip1 blocks DNA replication by binding to
proliferating cell nuclear antigen (PCNA) [5]; however, phos-
phorylation of p21 by Pim-1 disrupts the p21-PCNA complex,
thus stimulating resumption of S phase [6]. Pim-1 activity can
also promote progression through the G2/M transition. While
phosphorylation of Cdc25C by its associated kinase C-TAK1
blocks the ability of Cdc25C to activate the G2/M switch,
phosphorylation of C-TAK1 by Pim-1 abrogates this checkpoint
activity [7]. Furthermore, Pim-1 phosphorylation events promote
recruitment of nuclear mitotic factors to spindle poles, an
essential event in cell division [8]. Beyond enhancing cell
proliferation, Pim-1 can also suppress programmed cell death
by inactivating the pro-apoptotic proteins Bad [9] and ASK1
[10].
Additional cellular consequences of Pim-1 activity result from its
effects on transcriptional control of gene expression. For instance,
Pim-1-directed suppression of p27
Kip1 expression includes inhibi-
tion of p27 gene transcription, mediated by phosphorylation and
inactivation of the forkhead transcription factors FoxO1a and
FoxO3a [11]. Pim-1 also attenuates cytokine-induced transcrip-
tional programs mediated by the JAK-STAT pathways by
interacting with the suppressor of cytokine signaling proteins
Socs-1 and Socs-3 [12]. Phosphorylation by Pim-1 increases
cellular levels of Socs-1 by stabilizing the protein [13], thus
enhancing its ability to limit JAK-dependent activation of
downstream targets, particularly the transcription factor STAT5
[12]. In a third example, phosphorylation by Pim-1 was shown to
activate p100, a transcriptional coactivator that interacts with the
transcription factor c-Myb, leading to enhanced transcriptional
activation [14]. Finally, Pim-1 can also co-activate MYC-targeted
genes, which may involve phosphorylation of proximal histone
proteins or even MYC itself [15,16].
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ly impact cell proliferation and survival, involving direct effects on
the cell cycle and apoptotic machinery, as well as indirect effects
via re-programming transcriptional regulatory networks. Consis-
tent with this model, overexpressing Pim-1 from an immunoglob-
ulin enhancer induces lymphomas in transgenic mice [17], and
elevated Pim-1 levels have been associated with development of
hematopoietic cancers as well as aggressive tumors of the stomach
and prostate [16,18–21]. Although the consequences of Pim-1
overexpression on cellular growth and survival are severe, cells can
normally regulate Pim-1 levels through multiple mechanisms. In
hematopoietic cell models, transcription from the PIM1 gene is
dramatically enhanced by a variety of mitogenic stimuli, however,
induction is generally transient [22–25]. Furthermore, sequences
in the 59-untranslated region (59UTR) of PIM1 mRNA can
attenuate its translation [26], while turnover of Pim-1 protein is
regulated through interactions with heat shock protein 90 and
protein phosphatase 2A [27,28]. An early report characterizing
the kinetics of Pim-1 induction indicated that mitogens could also
modulate the decay kinetics of PIM1 mRNA. In primary
lymphocytes, treatment with concanavalin A and the phorbol
ester 12-O-tetradecanoyl-phorbol-13-acetate (TPA) transiently
elevated PIM1 mRNA levels [25]. However, while PIM1 mRNA
was moderately stable when maximally induced, it was destabi-
lized 17 hours following mitogenic stimulation.
Although investigations into the regulation of Pim-1 expression
havelargelyfocused onleukocytemodels,recent findingsthatPim-1
is overexpressed in some non-hematopoietic cancers (above) suggest
that mechanisms limiting its induction may be relevant to many
different cell types. In this study, we determined that PIM1 mRNA
is rapidly but transiently induced by mitogenic stimulation in
cultured human cell models representing three distinct tumorigenic
tissues, and in all cases involves rapid but reversible stabilization of
PIM1 mRNA. Destabilization of PIM1 mRNA several hours after
treatment with mitogens was accompanied by dramatically
enhanced expression of tristetraprolin (TTP), a tandem CCCH
zinc finger protein that targets mRNA substrates for rapid
degradation. TTP functions by interacting with several important
components of the cytoplasmic mRNA decay machinery, including
components of the 59-decapping complex, 39-deadenylating com-
plexes, and the 59R39 and 39R59 exonuclease activities required to
degrade the mRNA body [29,30]. In this work, we also show that
TTP binds PIM1 mRNA in cells and accelerates its decay, and that
this post-transcriptional regulatory circuit functions through AU-
rich elements (AREs) located near the 39-end of the transcript.
Correlation analyses suggest that expression of TTP and PIM1
mRNAs arecoordinated in diverse cell types. Given recent evidence
that a diverse array of mRNAs may associate with and/or be
regulated by TTP [31–33], we propose that mitogenic induction of
TTP serves to attenuate and temporally limit the activation of a
subset of mitogen-stimulated genes, including PIM1.
Materials and Methods
Ethics Statement
Allmouse experiments were conducted according to the USPublic
Health Service policy on the humane care and use of laboratory
animals. All animal procedures used in this study were approved by
the National Institute of Environmental Health Sciences Institutional
Animal Care and Use Committee (protocol number 97-06).
Cell Culture and Mitogenic Stimulation
MBA-MB-231, HeLa, and HepG2 cells were obtained from the
American Type Culture Collection. MDA-MB-231 and HeLa
lines were maintained in DMEM+10% fetal bovine serum (FBS) at
37uC and 5% CO2 while HepG2 cells were grown in MEM+10%
FBS under the same conditions. Primary murine embryonic
fibroblasts (MEFs) were isolated from E14.5 embryos of TTP
knockout mice (Zfp36
2/2) and wild-type littermates (Zfp36
+/+)a s
described previously [33] and were maintained in DMEM
containing 10% FBS, 100 U/ml penicillin, 100 mg/ml streptomy-
cin, and 2 mM L-glutamine. Experiments employing MEF
cultures were performed on cells prior to passage 12. Where
indicated, mitogenic stimulation of all cell models was performed
by serum starvation in medium containing 0.5% FBS for 16–
20 hours, followed by administration of fresh medium containing
10% FBS and 100 nM TPA. HeLa/Tet-Off cell clones stably
transfected with expression vectors encoding FLAG-tagged wild
type TTP (FLAG-TTPwt) or the TTP C147R mutant (FLAG-
C147R) were generated previously [34], and were maintained in
DMEM containing 10% FBS, 100 mg/ml G418, 100 mg/ml
hygromycin B, and 2 mg/ml doxycycline (Dox). As required,
FLAG-TTPwt or FLAG-C147R expression was induced by
removal of Dox from growth media for 24 hours.
Measurements of PIM1 mRNA Levels and Decay Kinetics
Total RNA was purified from cultured cell lines using TRIzol
reagent (Invitrogen) according to the manufacturer’s instructions.
RNA samples were analyzed for PIM1 mRNA by qRT-PCR using
the iScript One-Step RT-PCR Kit with SYBR Green (Bio-Rad) in
parallel reactions programmed with human PIM1 and GAPDH
amplification primers (for MBA-MB-231, HeLa, and HepG2
RNA samples; all qRT-PCR primers are listed in Table S1).
Corresponding murine PIM1 and GAPDH PCR primers were
used for RNA samples from MEF cultures. Relative levels of PIM1
mRNA were calculated from threshold cycle numbers (Ct) after
normalization to endogenous GAPDH mRNA abundance using
the 2
DDCt method. Each data point was taken as the mean 6
standard deviation from quadruplicate qRT-PCR reactions for
each RNA sample. The decay kinetics of PIM1 mRNA was
measured by actinomycin D (actD) time course assay. Briefly, total
RNA samples were purified from cultured cells at various times
following treatment with actD (5 mg/ml), which inhibits global
transcription. Time courses were limited to 4 h to avoid
complicating cellular mRNA decay pathways by actD-enhanced
apoptosis [35]. Relative PIM1 mRNA levels remaining at each
time point were quantified by qRT-PCR (described above),
normalized to GAPDH mRNA, and plotted as a function of time
following actD treatment. From these plots, first-order mRNA
decay constants (k) were resolved by nonlinear regression (PRISM
v3.03, GraphPad), from which PIM1 mRNA half-lives were
calculated using t1/2=ln2/k. Tabulated PIM1 mRNA half-life
values are based on the mean 6 standard deviation of n
independent time-course experiments to permit pair-wise statisti-
cal comparisons (described below).
b-globin Reporter mRNA Decay Assays
The effects of PIM1 mRNA 39UTR sequences on TTP-directed
mRNA decay were analyzed using b-globin (bG)-chimeric
transcripts essentially as described [36]. Briefly, selected sequences
were amplified by PCR from a PIM1 cDNA clone (GenBank
accession NM_002648; GeneCopoeia) using Pfu DNA polymerase.
A PIM1 cDNA fragment encoding a mutated ARE domain was
synthesized by GenScript. These fragments were subcloned
downstream of the bG translational termination codon in vector
pTRERb, which expresses the rabbit bG gene under the control of
a tetracycline-responsive promoter [37]. The fidelity of all
recombinant plasmids was verified by restriction mapping and
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transfected into HeLa/Tet-Off cells (Clontech) in 6-well plates
along with the control plasmid pEGFP-C1 (200 ng; Clontech),
encoding the enhanced green fluorescent protein (EGFP), using
Superfect reagent (Qiagen). Where indicated, cells were cotrans-
fected with vectors (100 ng) expressing FLAG-TTPwt or FLAG-
TTP C147R from constitutive promoters, or with an empty vector
(pcDNA) as a negative control. After 24 h, transcription from the
bG reporter plasmids was arrested by adding doxycycline (Dox;
2 mg/ml). At selected time points thereafter, DNA-free RNA was
harvested using the SV RNA Purification Kit (Promega) and
analyzed for bG-reporter and EGFP mRNA levels by multiplex
qRT-PCR using the qScript One-Step qRT-PCR Kit (Quanta
Biosciences) with bG and EGFP Taqman primer/probe sets
(Table S1) as described previously [36], with each data point taken
as the mean 6 standard deviation of five qRT-PCR reactions.
After normalization to EGFP mRNA concentrations, the levels of
individual bG-reporter mRNAs were plotted as a function of time
following administration of Dox to resolve mRNA decay constants
as described above.
Western Blots
Rabbit anti-TTP was from Abcam. Rabbit anti-Pim-1, mouse
anti-FLAG M2 monoclonal, horseradish peroxidase-conjugated
anti-GAPDH, and all secondary antibodies were from Sigma.
Whole cell lysates were collected by washing cell monolayers with
phosphate-buffered saline and then scraping in 26 SDS-PAGE
buffer (250 mM Tris [pH 6.8] containing 2% SDS, 10 mM DTT,
10% glycerol, and 0.05% bromophenol blue). Cell lysates were
heated to 100uC for 5 min, then clarified by centrifugation at
16,0006 g for 10 min to precipitate cell debris. Clarified lysates
were fractionated through 10% SDS polyacrylamide gels and
transferred to a nitrocellulose membrane which was then blocked
with 10% nonfat milk and incubated overnight with primary
antibody at 4uC. After washing, blots were then incubated with
peroxidase-conjugated secondary antibodies for an hour and
developed using the Western Lightning Plus-ECL kit (PerkinEl-
mer).
Immunoprecipitation and RT-PCR of Ribonucleoprotein
Complexes
HeLa cells were lysed in PLB buffer (10 mM HEPES [pH 7.5]
containing 100 mM KCl, 5 mM MgCl2, 0.5% IGEPAL CA630,
and 1 mM dithiolthreitol) containing 250 U/ml RNaseOUT
(Invitrogen) and 16complete protease inhibitor cocktail (Roche)
on ice for 10 minutes. Ribonucleoprotein (RNP) complexes
containing FLAG-TTPwt or FLAG-TTP C147R were fraction-
ated from these lysates by incubation with 100 ml of a 50% (v/v)
suspension of Protein-A Sepharose beads (Sigma) pre-coated with
30 mg M2 anti-Flag monoclonal antibody (Sigma) for 2 h at 4uC
with mixing. Parallel fractionations programmed with mouse
IgG1- (BD Pharmingen) loaded beads served as negative controls.
After incubation beads were washed 5 times with NT2 buffer
(50 mM Tris [pH 7.4] containing 150 mM NaCl, 1 mM MgCl2,
0.05% Triton X-100), and then incubated with 100 ml NT2 buffer
containing RNase-free DNase I (20 U) for 15 min at 30uCt o
eliminate DNA from samples. Subsequently, beads were washed
twice with 1 ml NT2 buffer, and then incubated in 100 ml NT2
buffer containing 0.1% SDS and 0.5 mg/ml proteinase K for
15 min at 55uC to digest proteins bound to the beads. After
extraction with phenol:chloroform (1:1), the RNA from each
ribonucleoprotein immunoprecipitation (RNP-IP) was then re-
verse-transcribed and specific transcripts quantified using the
iScript One-step RT-PCR SYBR Green kit (Bio-Rad) with primer
sets listed in Table S1.
Biotin-RNA Pull-down Assay
Interactions between FLAG-TTP proteins expressed in HeLa
cells and RNA substrates were evaluated in vitro using a
modification of the biotin-RNA pull-down assay described by
Wang et al. [38]. Briefly, in vitro transcription templates encoding
the PIM1 ARE, a mutated ARE fragment, or a coding region
sequence from PIM1 mRNA downstream of the T7 promoter
were generated by PCR using Pfu DNA polymerase (Stratagene)
from appropriate primers. Biotin-labeled riboprobes were then
generated using the MegaShortScript T7 in vitro transcription kit
(Ambion) incorporating UTP and biotin-16-UTP (Roche) at a 9:1
ratio. Crude cytoplasmic extracts were prepared from HeLa/Tet-
Off cells or clonal lines expressing FLAG-TTPwt or FLAG-TTP
C147R by scraping into lysis/wash buffer (10 mM TrisHCl
[pH 7.5] containing 100 mM KCl, 2.5 mM MgCl2,2 m M
dithiolthreitol, and 1% IGEPAL-CA630) supplemented with a
protease inhibitor cocktail (1 mg/ml leupeptin, 1 mg/ml pepstatin
A, and 0.1 mM phenylmethylsulfonyl fluoride). Cells were broken
using a Dounce homogenizer and nuclei pelleted by centrifugation
at 10006g for 10 minutes. Protein concentrations were measured
using the Bio-Rad Protein Assay reagent. Biotin-RNA pull-down
reactions were assembled with 50 mg protein extract and 20 pmol
biotin-RNA. After incubation for 30 minutes at room tempera-
ture, biotin-RNA:protein complexes were isolated using strepta-
vidin-agarose beads (Fluka), washed twice in lysis/wash buffer,
then dissociated by re-suspension in 26 SDS-PAGE buffer at
100uC for 5 minutes. Co-purification of FLAG-tagged TTP
proteins was determined using Western blots.
Statistics
Comparisons of mRNA levels and decay kinetics were done
using the unpaired t test, while correlation analyses used the
Spearman nonparametric test. In all cases, differences yielding
p,0.05 were considered significant.
Results
Transient Mitogenic Stimulation of PIM1 Expression
Includes Reversible mRNA Stabilization in Diverse Human
Cultured Cell Models
Previous studies showed that mitogens can transiently induce
PIM1 gene transcription in a variety of hematopoietic cell models
(described under Introduction), however, few details are available
regarding the regulatory mechanisms responsible for temporal
control of PIM1 expression. Furthermore, little is known about the
regulation of PIM1 expression in non-hematopoietic cells, even
though it is overexpressed in some solid tumors. The report by
Wingett et al. [25] raised the interesting possibility that the
diminution of PIM1 mRNA that followed its induction by
mitogens in primary lymphocytes was accompanied by destabili-
zation of the transcript. In order to characterize molecular events
contributing to transient accumulation of PIM1 mRNA, and to
ascertain whether these mechanisms also applied to non-
hematopoietic cell types, it was first necessary to determine
whether PIM1 mRNA was regulated by mitogenic stimulation in
tractable cultured cell systems. To this end, we monitored PIM1
mRNA levels in serum-starved HeLa (human cervical adenocar-
cinoma), HepG2 (human hepatoblastoma), and MDA-MB-231
(human breast adenocarcinoma) cells, then measured changes in
PIM1 mRNA expression as a function of time following mitogenic
stimulation using serum+TPA. In all three cell models, PIM1
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but returned to near basal levels shortly thereafter (Figure 1).
To determine whether mitogen-induced changes in PIM1
mRNA levels included modulation of mRNA turnover kinetics,
actD time course assays were used to measure PIM1 mRNA decay
rates in cells prior to or at selected times following mitogenic
stimulation. In HeLa cells, PIM1 mRNA decay was well described
by a first-order kinetic model, which in uninduced cells yielded an
mRNA half-life of approximately 2.4 hours (Figure 2 and Table 1).
One hour following application of serum+TPA, PIM1 mRNA was
stabilized greater than 2-fold. However, this mitogen-induced
inhibition of PIM1 mRNA decay was reversed 4 hours following
stimulation of HeLa cells (Table 1), concomitant with decreasing
levels of the PIM1 transcript (Figure 1). In HepG2 and MDA-MB-
231 cells, similar trends in PIM1 mRNA decay kinetics were
observed, although the stabilization phase was even more
pronounced, with PIM1 mRNA exhibiting a half-life of .10 hours
following 1 hour serum+TPA treatment (Table 1). These data
indicate that mitogenic stimulation quickly stabilizes PIM1 mRNA
in concert with the previously described activation of PIM1 gene
transcription [22–24,39]. However, following this transient
accumulation phase PIM1 mRNA is destabilized, which likely
accelerates the rate at which PIM1 mRNA returns to basal levels
in the cell. Finally, these data show that this reversible mRNA
stabilization event occurs in a wide range of cell types.
Post-mitogen Suppression of PIM1 mRNA Coincides with
Induction of TTP, which Binds and Destabilizes the PIM1
Transcript
Regulated mRNA decay is generally directed by discrete cis-
acting sequences within affected transcripts. The best character-
ized sequence determinants of mRNA stability are AREs, which
are located within the 39UTRs of many mRNAs that encode
oncoproteins and inflammatory mediators [40]. AREs function by
associating with cellular ARE-binding proteins, which may
positively or negatively influence mRNA decay rates or transla-
tional efficiency [41,42]. Towards the 39-end of the PIM1 mRNA
39UTR is a U-rich domain containing several overlapping copies
of the AUUUA motif common among ARE sequences (Figure 3A).
A further indication that this domain might contribute to the
regulated decay of PIM1 mRNA was previously reported, as a
germ-specific PIM1 transcript found in rat testes which lacks the
distal 39UTR is significantly more stable than the somatic PIM1
mRNA [25]. Although many different factors can influence
mRNA decay kinetics through AREs, two observations suggested
that the ARE-binding, mRNA-destabilizing factor TTP might
contribute to the regulated decay of PIM1 mRNA following
mitogenic stimulation. First, PIM1 mRNA levels were suppressed
2–4 hours following stimulation with serum+TPA in several
cultured cell models (Figure 1) involving destabilization of PIM1
mRNA (Figure 2), while TTP expression is induced by mitogenic
stimuli in some cell types [43,44]. Second, the ARE-like domain
within the PIM1 mRNA 39UTR contains several sequences of the
type UUAUUUAUU (Figure 3A), which were previously
identified as high affinity TTP binding sites [45]. Together, these
observations raise the possibility that mitogen-stimulated produc-
tion of TTP might be responsible for limiting expression of PIM1
mRNA once TTP protein has accumulated in the cell.
To test this model, we first used Western blots to assess TTP
protein levels in each cell model as a function of time following
mitogenic stimulation. Previously, we and others have shown that
TTP is very weakly expressed in a variety of exponentially growing
cultured cancer cell lines including HeLa and MDA-MB-231
[34,46]. Similarly, we observed that TTP protein was barely
detectable in serum-starved HeLa, HepG2, or MDA-MB-231 cells
(Figure 3B). However, TTP expression was dramatically enhanced
in each of these cell models following addition of serum+TPA.
TTP protein reached peak levels within 2–4 hours following
mitogenic stimulation depending on cell type. In HeLa and MDA-
MB-231 cells, TTP protein levels then decreased as a function of
time, while in HepG2 cells high TTP expression was maintained
for at least 12 hours. At later time points slower mobility bands
appeared on TTP immunoblots consistent with post-translation-
ally modified proteins. These modifications are likely phosphor-
ylation events; TTP phosphorylation by the p38
MAPK-activated
kinase MK2 has been shown to regulate both the stability and
subcellular distribution of the protein [29]. However, since post-
mitogen destabilization of PIM1 mRNA (4 h post-induction;
Table 1) was observed concomitant with dramatically elevated
TTP expression, we next tested whether TTP could interact with
endogenous PIM1 transcripts. For these experiments, we utilized
previously described HeLa/Tet-Off cell models that express
FLAG-tagged versions of wild type TTP (FLAG-TTPwt) or the
TTP C147R mutant protein under the control of a tetracycline-
regulated promoter [34]. The C147R mutant protein serves as a
negative control, since disruption of this Zn
2+-coordinating residue
within the C-terminal zinc finger domain abrogates RNA-binding
activity [47]. In RNP-IP assays programmed with anti-FLAG
antibodies, PIM1 mRNA was readily detected in immunoprecip-
itates from cells expressing wild type TTP but not from
Figure 1. Transient induction of endogenous PIM1 mRNA by mitogenic stimuli in cancer cell lines. Total RNA was isolated from HeLa,
HepG2, and MDA-MB-231 cells at selected times following stimulation with serum+TPA as described in ‘‘Materials and Methods’’. Bars represent the
relative levels of PIM1 mRNA determined by qRT-PCR and normalized to GAPDH mRNA (mean 6 SD of quadruplicate qRT-PCR reactions).
Independent replicate experiments yielded similar results.
doi:10.1371/journal.pone.0033194.g001
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(Figure 4A), indicating that PIM1 mRNA selectively associates
with the wild type FLAG-TTP protein.
Given that TTP can interact with PIM1 mRNA, the next
objective was to determine whether TTP influences the expression
of this transcript in cells. Real-time qRT-PCR assays showed that
PIM1 mRNA levels were suppressed by over 80% in HeLa/Tet-
Off cells expressing FLAG-TTPwt relative to untransfected cells
and 70% relative to C147R-expressing cells (Figure 4B), indicating
that maximal suppression of PIM1 mRNA occurs only in the
presence of functional TTP. Since TTP normally enhances
degradation of substrate mRNAs [48], we then used actD time
course assays to determine whether FLAG-TTPwt suppresses
PIM1 mRNA levels by accelerating its decay kinetics (Figure 4C).
In untransfected HeLa/Tet-Off cells, PIM1 mRNA decayed with
a half-life of 3.0460.36 h (n=3). In cells expressing FLAG-TTP
C147R, PIM1 mRNA was slightly more stable (t1/2=
4.5960.85 h; n=4), a small but statistically significant (p=0.033)
effect that may reflect a dominant negative activity by the C147R
protein on cellular mRNA decay kinetics. Other RNA binding-
defective TTP mutants are known to behave similarly [32,47],
possibly as a result of sequestering ancillary mRNA-degrading
activities that bind flanking TTP protein domains [49,50].
Curiously, PIM1 mRNA levels were modestly decreased in
C147R-expressing relative to untransfected cells (Figure 4B),
despite being slightly more stable in the C147R line. One
possibility is that C147R-induced perturbations in the cellular
mRNA decay machinery indirectly contribute to a slight decrease
in the transcription of PIM1 (and likely many other) genes,
although through an unknown mechanism. However, in cells
expressing FLAG-TTPwt, PIM1 mRNA decayed with a half-life of
1.7360.18 h (n=4), which was significantly faster than the
turnover rate of this transcript in either untransfected
(p=0.0013) or C147R-expressing cells (p=0.0006). Together,
these data show that wild type TTP can associate with the PIM1
transcript in cells, and that this interaction decreases PIM1 mRNA
levels by accelerating its decay. Finally, accelerated decay of PIM1
mRNA by TTP also impacts levels of the encoded protein, since
Western blots show a dramatic decrease in Pim-1 protein in
HeLa/Tet-Off cells expressing FLAG-TTPwt relative to untrans-
fected cells (Figure 4D). Consistent with comparisons of PIM1
mRNA (Figure 4B), expression of the TTP C147R mutant also
decreased Pim-1 protein levels modestly, however, they remained
substantially higher than in cells expressing comparable amounts
of wild type TTP.
TTP Binds and Destabilizes PIM1 mRNA via AU-rich
Sequences in its Distal 39UTR
TTP is known to target a variety of ARE-containing mRNAs,
particularly those that encode cytokines and lymphokines [31].
Furthermore, in vitro binding studies identified UUAUUUAUU as a
high affinity TTP-binding motif [45], several copies of which are
localized to the distal 39UTR of PIM1 mRNA (Figure 3A). To
determine whether this ARE-like domain within the PIM1 39UTR
was involved in TTP-directed control of mRNA decay, a series of
PIM1 39UTR-derived fragments were inserted into the 39UTR of a
b-globin (bG) reporter gene downstream of a Tet-responsive
promoter (Figure 5A). These vectors were co-transfected along with
plasmids expressing wild type or C147R mutant forms of FLAG-
TTP into HeLa/Tet-Off cells, permitting measurement of reporter
mRNA decay rates using Dox time course assays. A bG reporter
mRNA containing the entire PIM1 39UTR decayed with a half-life
of approximately 1.6 hours in HeLa/Tet-Off cells when co-
transfected with an empty control vector (Figure 5B). In cells
expressing wild type FLAG-TTP, this reporter transcript decayed
with a half-life of 56 minutes, significantly faster than in cells co-
Figure 2. Control of PIM1 mRNA turnover in mitogen-stimulated HeLa cells. The decay kinetics of PIM1 mRNA were measured in serum-
starved HeLa cells (uninduced) or at selected times after stimulation with serum+TPA using actD time course assays. For each experiment, the fraction
of PIM1 mRNA remaining was plotted as a function of time following inhibition of transcription by actD, and PIM1 mRNA decay constants resolved by
nonlinear regression to a first-order decay model (lines). Average decay constants measured across replicate independent experiments are listed in
Table 1.
doi:10.1371/journal.pone.0033194.g002
Table 1. PIM1 mRNA decay kinetics during mitogenic
stimulation of cancer cell lines.
cell line serum+TPA
a t1/2 (h)
b n
HeLa unstimulated 2.3860.16 3
1 h 5.2760.15 3
4 h 2.3360.09 3
HepG2 unstimulated 1.6360.12 3
1h .10 3
4 h 2.6860.21 3
MDA-MB-231 unstimulated 3.0560.20 3
1h .10 3
4 h 3.3660.58 3
aCultures were incubated for 16–20 h in medium containing 0.5% serum prior
to each experiment. Where indicated, cells were stimulated by adding medium
containing serum (10%) and TPA (100 nM) for indicated periods prior to
inhibition of transcription with actD.
bFirst-order mRNA decay constants (k) were resolved for each cell population by
actD time course assay as described under ‘‘Materials and Methods’’. mRNA
half-lives were then calculated using t1/2=ln2/k. Quoted values represent the
mean 6 SD across n independent time course experiments.
doi:10.1371/journal.pone.0033194.t001
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(p=0.0003) plasmids (Table 2). By contrast, a reporter mRNA
lacking the PIM1 ARE (DARE) exhibited similar decay kinetics in
the presence or absence of functional TTP, indicating that the ARE
domain is required for TTP-directed control of mRNA turnover.
This was further supported by decay of a bG reporter mRNA
containingthePIM1AREalone,which wassignificantlydestabilized
in cells expressing wild type TTP relative to cells co-transfected with
the C147R mutant (p=0.0087) or empty vector control (p=0.0094).
Finally, we tested whether the UUAUUUAUU sequences located at
the 39-end of the ARE domain specifically contributed to TTP-
dependent mRNA destabilization by measuring the decay kinetics of
a modified bG-PIM1 ARE reporter transcript (bG-PIM1 AREmut)
containing a series of URC substitutions within these motifs
(Figure 5A). Similar to the PIM1 DARE reporter, turnover of the
bG-PIM1 AREmut mRNA was completely unresponsive to TTP
expression (Table 2), indicating that the UUAUUUAUU motifs
located within the distal portion of the ARE domain are essential for
targeted mRNA decay through TTP.
To determine whether TTP could physically interact with the
ARE from PIM1 mRNA, biotin-labeled riboprobes were synthe-
sized thatencodeda171-nucleotideregionspanningthePIM1ARE
or a comparably sized fragment from the 39-end of the PIM1 coding
sequence (Figure 5A). When incubated with crude cytoplasmic
extracts from untransfected HeLa/Tet-Off cells or cultures
expressing FLAG-TTPwt or FLAG-TTP C147R, the wild type
protein co-purified with the biotin-labeled ARE fragment over a
streptavidin resin, while the mutant protein did not (Figure 5C).
Neither FLAG-TTP protein co-purified with the PIM1 mRNA
coding sequence fragment. Similarly, neither protein was recovered
in complexes with the biotin-labeled PIM1 AREmut probe.
Together, these data demonstrate that the UUAUUUAUU-
enriched sequences at the 39-end of the ARE-like domain within
the PIM1 39UTR bind TTP, and are required for acceleration of
mRNA decay in the presence of this factor.
Expression of PIM1 and TTP mRNAs are Coordinately
Regulated in Various Tissues
Our working model is that mitogenic stimulation concomitantly
induces expression of both PIM1 (Figure 1) and TTP (Figure 3B),
Figure 4. Functional association of TTP with PIM1 mRNA in
HeLa cells. (A) RNP-IP experiments were performed using control IgG
or anti-FLAG antibodies and lysates from untransfected HeLa/Tet-Off
cells (ut) or stable clonal lines expressing FLAG-TTPwt or FLAG-TTP
C147R as described in ‘‘Materials and Methods’’. Immunoprecipitated
material was then screened for PIM1 mRNA by quantitative real-time RT-
PCR and normalized to GAPDH mRNA (mean 6 SD of three reactions).
Independent replicate experiments yielded similar results. (B) Relative
levels of PIM1 mRNA were measured in untransfected versus FLAG-
TTPwt- or FLAG-TTP C147R-expressing HeLa cells. Bars represent the
mean 6 SD of quadruplicate qRT-PCR reactions normalized to GAPDH
mRNA. (C) The decay kinetics of PIM1 mRNA was measured in HeLa cell
models using actD time course assays as described in Figure 2. mRNA
half-lives calculated from independent replicate experiments are
provided in the text. (D) Western blot analyses using antibodies
targeting specified proteins in HeLa/Tet-Off cell models, with positions
of molecular weight markers (in kDa) shown at left.
doi:10.1371/journal.pone.0033194.g004
Figure 3. Induction of the ARE-binding protein TTP in mitogen-stimulated cancer cell lines. (A) Schematic of PIM1 mRNA showing a
putative ARE sequence within the distal 39UTR. Sequences corresponding to consensus TTP-binding sites are underlined. (B) Western blots showing
the induction of TTP protein at selected times following mitogenic stimulation of cancer cell lines. Whole cell lysates were prepared at indicated time
points following addition of serum+TPA to serum-starved cultures. GAPDH levels were used to normalize protein loading. The positions of molecular
weight markers (in kDa) are indicated left of each blot.
doi:10.1371/journal.pone.0033194.g003
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PLoS ONE | www.plosone.org 6 March 2012 | Volume 7 | Issue 3 | e33194Figure 5. Localization of TTP-responsive elements to an ARE-like sequence in the PIM1 mRNA 39UTR. (A) Schematic of the 39-end of the
PIM1 mRNA coding sequence (black box) and complete 39UTR, including the ARE domain (white box). The scale bar (top) is relative to the translational
initiation codon. The positions of biotin-labeled riboprobes corresponding to the PIM1 ARE and coding sequence fragment (CDS) are shown as black
bars above the mRNA schematic. Bars below delineate PIM1 39UTR domains that were subcloned downstream of the translational termination codon
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the amplitude and duration of PIM1 mRNA accumulation by
targeting this transcript for degradation. While this relationship was
consistent among the cultured cell models surveyed in this work, we
next tested whether PIM1 and TTP expression might be
coordinately regulated in vivo by comparing PIM1 and TTP mRNA
levels among gene array datasets derived from cohorts of human
tissues (Figure 6). The datasets tested represented: (i) a collection of
171 prostate samples, which included normal and transformed
tissues [51], (ii) 94 breast tumors[52], and(iii) CD138+ cells purified
from the bone marrow of 50 multiple myeloma (MM) patients [53].
In all cases, statistically significant positive correlations were
observed between PIM1 and TTP mRNA levels. If both PIM1
andTTPwere constitutivelyexpressed,one wouldexpecta negative
correlation between these mRNAs, since the steady-state level of
PIM1 mRNAwouldbe suppressed byTTP-directeddestabilization.
However, since both are inducible genes, these data are most
consistent with a model whereby PIM1 and TTP expression are
concomitantly induced by common stimuli, and that this relation-
ship is conserved across diverse tissue types.
Coordinated Induction of PIM1 and TTP Limits the
Magnitude and Duration of PIM1 mRNA Accumulation
Following Mitogenic Stimulation
Finally, to test whether mitogenic induction of TTP is required
to attenuate PIM1 expression in mitogen-stimulated cells, PIM1
mRNA levels were compared in MEF cultures derived from TTP
knockout mice (TTP
2/2) versus wild type littermates (TTP
+/+)a sa
function of time following treatment with serum+TPA. Similar to
the cultured human cell lines (Figure 3B), mitogenic stimulation
rapidly and potently increased TTP protein levels in TTP
+/+
MEFs (Figure 7A), while no TTP protein was detected in the
TTP
2/2 line. In TTP
+/+ cells, PIM1 mRNA was rapidly but
transiently induced following addition of serum+TPA, increasing
approximately 3.5-fold within 2 hours (Figure 7B). By contrast,
mitogenic stimulation of TTP
2/2 MEFs increased PIM1 mRNA
to levels 1.8-fold higher than those observed in the corresponding
TTP
+/+ line. Furthermore, enhanced PIM1 levels were observed
for a longer period following stimulation of TTP
2/2 versus TTP
+/+
MEFs. Four hours post-stimulation, PIM1 mRNA was still
elevated 3-fold above uninduced levels in TTP
2/2 cells, while in
cells expressing TTP, PIM1 mRNA had returned to near basal
levels at this point. Finally, ActD time course assays performed
after 2 h induction showed that PIM1 mRNA decayed over 3.5-
fold faster in TTP
+/+ versus TTP
2/2 MEFs (Figure 7C). Together,
these data show that concomitant induction of TTP limits the
accumulation of PIM1 mRNA following mitogenic stimulation by
accelerating decay of this transcript.
Discussion
Mitogens rapidly induce expression from the PIM1 gene in
many different cell backgrounds (Figure 1) [23–25]. The resulting
enrichment of Pim-1 protein levels activates several nuclear and
cytoplasmic signaling programs that promote cell proliferation and
suppress apoptosis (described under ‘‘Introduction’’). However,
prolonged or constitutive elevation of Pim-1 levels can contribute
to hyperproliferative or neoplastic syndromes [16,17,20,21],
indicating that it is essential to restrict PIM1 expression. In this
study, we show that induction of PIM1 mRNA following mitogenic
stimulation with serum+TPA is temporally limited in several cell
models (Figure 1), and that rapid restoration to basal expression
levels involves acceleration of mRNA decay in each case (Table 1).
This post-induction enhancement of PIM1 mRNA turnover
coincides with accumulation of the ARE-binding protein TTP
(Figure 3), which binds and destabilizes PIM1 mRNA (Figure 4) via
a series of UUAUUUAUU motifs located within an ARE-like
domain in the PIM1 39UTR (Figure 5). Finally, we provide
evidence that expression of TTP and PIM1 are correlated in many
human tissues (Figure 6), and that mitogenic stimulation can
induce PIM1 mRNA to a greater degree in TTP-deficient cells
(Figure 7). Together, these data indicate that concomitant
induction of TTP likely contributes to limiting the amplitude
and duration of PIM1 mRNA accumulation following mitogenic
stimulation.
Recent ribonome-wide surveys of TTP-regulated mRNAs by
large-scale RNP-IP [31], or differential mRNA levels [32] or
stability [33] in cells expressing or lacking functional TTP have
identified several hundred transcripts that may bind and/or be
of the bG gene for reporter mRNA decay assays. At the bottom is the sequence at the extreme 39-end of the ARE domain that contains known high
affinity TTP-binding motifs. In the bG-PIM1 AREmut reporter mRNA and biotin-labeled AREmut RNA probe, these motifs were disrupted by mutating
underlined uridylate residues to cytidines. (B) Decay rates of bG-PIM1 chimeric reporter mRNAs were resolved by Dox time course assays in HeLa/Tet-
Off cells co-transfected with an empty vector (pcDNA; solid circles, solid lines) or vectors expressing FLAG-TTPwt (open circles, dashed lines) or FLAG-
TTP C147R (triangles, dotted lines) as described under ‘‘Materials and Methods’’. mRNA half-lives resolved from multiple independent experiments are
summarized in Table 2. (C) Western blots probed with indicated antibodies (Ab) show levels of FLAG-TTP wt and C147R mutant proteins (top panel)
and GAPDH (second panel) in crude cytoplasmic extracts prepared from untransfected HeLa/Tet-Off cells (ut) or stable clonal lines expressing each
FLAG-TTP variant. Samples of each lysate were fractionated using biotin-RNA pull-down assays programmed with riboprobes encoding a PIM1 coding
sequence fragment (CDS), the PIM1 ARE or the ARE mutant containing the URC substitutions specified above (AREmut). FLAG-TTP proteins co-
purifying with each riboprobe were detected by Western blot (bottom panels). The positions of molecular weight markers (in kDa) are shown to the
left of each Western blot panel.
doi:10.1371/journal.pone.0033194.g005
Table 2. Decay kinetics of bG-PIM1 chimeric mRNAs in
transfected HeLa cells.
mRNA Co-transfection t1/2 (h)
a n
bG-PIM1 39UTR pcDNA 1.6460.09 3
TTPwt 0.9360.09 3
TTP C147R 1.6660.11 4
bG-PIM1 DARE pcDNA 3.8860.71 3
TTPwt 3.6760.22 3
TTP C147R 4.5260.49 4
bG-PIM1 ARE pcDNA 1.4260.07 3
TTPwt 0.8960.18 3
TTP C147R 1.4560.09 3
bG-PIM1 AREmut pcDNA 2.5860.56 4
TTPwt 2.9660.54 4
TTP C147R 2.9360.17 3
aFirst-order constants (k) describing the decay kinetics of indicated bG-chimeric
mRNAs were measured in HeLa/Tet-Off cells co-transfected with indicated
expression plasmids by Dox time course assays as described under ‘‘Materials
and Methods’’ and in Figure 5. mRNA half-lives were calculated using t1/2=ln2/
k. Quoted values represent the mean 6 SD for n independent experiments.
doi:10.1371/journal.pone.0033194.t002
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includes many mRNAs that encode regulators of cell proliferation
and survival including cyclin G2, interleukins -10 and -15, and the
polo-like kinases Plk2 and Plk3. Other known mRNA substrates of
TTP encode factors that promote angiogenesis and tumor
metastasis like vascular endothelial growth factor [34,54] and
urokinase plasminogen activator [32], as well as a diverse
collection of inflammatory mediators including TNFa and
cyclooxygenase 2 [55,56]. As such, the mRNA-destabilizing
activity of TTP likely serves as a general mechanism to limit
levels of many transcripts whose uncontrolled expression can elicit
severe pathological consequences. However, the ordered activa-
tion of positive (transcriptional induction, mRNA stabilization)
and negative (TTP expression) regulatory mechanisms influencing
PIM1 mRNA following mitogenic stimulation characterized in this
work highlights an expanded role for TTP in controlling
expression of its mRNA targets. By coordinating the induction
of TTP along with TTP substrate mRNAs in response to specific
stimuli, cells may buffer perturbations in gene regulatory networks
by limiting the extent and duration of target mRNA accumulation.
The utility of regulated mRNA decay in limiting acute mRNA
induction following inflammatory stress was recently highlighted in
a survey of transcript levels and stability in lipopolysaccharide-
stimulated bone marrow-derived macrophages [57]. Here, brief
(30 min) lipopolysaccharide exposure stabilized a diverse array of
ARE-containing transcripts; however, a subset of these mRNAs
including those encoding endothelin 1, TNFa, the chemokine
CXCL1, and even TTP itself were again rapidly degraded 6 h
post-stimulation. This study suggests that post-transcriptional
mechanisms targeting AREs may exert a limiting influence on
the expression of many genes.
Although TTP expression is induced by selected mitogenic
and inflammatory stimuli concomitant with activated transcrip-
tion of some TTP substrate mRNAs including PIM1 (discussed
above), few details are available regarding the mechanisms
responsible for coordinated transcription from these genes. For
example, increased TTP expression in lipopolysaccharide-
stimulated cultured macrophages requires p38
MAPK [58], while
serum induction of TTP in fibroblast models was strongly but
not completely dependent on an intronic sequence element that
bound the transcription factor Sp1 [59]. By contrast, neither of
these mechanisms has yet been implicated in the regulation of
the PIM1 gene, although prolactin activates its transcription in a
lymphoma model through several proximal upstream promoter
elements [22], and also requires activation of the Akt kinase
[60]. However, a recent ribonome-scale survey of epidermal
growth factor-stimulated genes in HeLa cells showed that
induction of TTP mRNA coincided with expression of several
transcription factors including junB and ATF3, suggesting that
an AP-1-based transcription circuit could be responsible for
coordinating these events [61]. Elucidating the molecular
mechanisms responsible for coordinating transcription of TTP
and its target mRNAs thus remains an intriguing topic for future
study.
Data presented in this work show that TTP destabilizes PIM1
mRNA through interactions with an ARE sequence in the PIM1
mRNA 39UTR, and that this regulatory mechanism suppresses
PIM1 expression 4 hours following mitogenic stimulation
(Figure 1 and Table 1). However, in quiescent cells PIM1 mRNA
also decayed rapidly but was dramatically stabilized shortly
following exposure to serum+TPA, all in the absence of
detectable TTP protein (Figure 3). These observations prompt
another interesting question, in that the mechanism(s) responsible
for initial stabilization of PIM1 mRNA following mitogen
exposure remain unknown. Some results from this study suggest
that constitutive decay of PIM1 mRNA may also be mediated by
its ARE domain, since the bG reporter mRNA lacking the PIM1
ARE (DARE) was stabilized .2-fold versus reporter transcripts
containing the complete PIM1 39UTR (p=0.0056) or the ARE
alone (p=0.0039), even in the absence of TTP (Table 2).
Accordingly, a likely model is that an alternative ARE-binding
activity is responsible for the rapid decay of PIM1 mRNA in
unstimulated cells, which may be inactivated or displaced shortly
following mitogenic simulation. Over 20 different factors have
been shown to bind AREs, although the functional significance of
these interactions has not been resolved in most cases [41,42].
However, recent studies on the regulation of selected ARE-
binding proteins suggest some potential candidates. AUF1 is a
family of four related proteins generated by alternative splicing
from a common pre-mRNA [62]. Each isoform is capable of
binding ARE sequences with varying degrees of affinity [63], but
the major cytoplasmic isoforms, termed p37
AUF1 and p40
AUF1,
are most closely associated with destabilization of mRNA
substrates [64,65]. In unstimulated THP-1 monocytes, poly-
some-associated p40
AUF1 is phosphorylated on Ser83 and Ser87.
However, stimulation of THP-1 cells with TPA induces rapid
Figure 6. Coordinated expression of PIM1 and TTP mRNAs in selected human tissues. Levels of PIM1 and TTP mRNAs were extracted from
gene array datasets derived from a panel of human non-transformed (normal) and tumorous prostate tissues (Gene Expression Omnibus accession
no. GSE6919), breast tumors (Gene Expression Omnibus accession no. GSE2294), and CD138+ cells purified from bone marrow of multiple myeloma
(MM) patients (Gene Expression Omnibus accession no. GSE2912). Correlation between levels of PIM1 and TTP mRNAs was analyzed using the
Spearman nonparametric test. Correlation coefficients (r) and associated p values are listed in each panel. The dotted lines indicate the 95%
confidence intervals of each regression solution.
doi:10.1371/journal.pone.0033194.g006
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AUF1 concomitant with stabilization of
mRNA targets [66]. A second potential trans-regulator of PIM1
mRNA decay is HuR. This ubiquitously expressed protein
stabilizes a wide variety of ARE-containing mRNAs [67–69] by
forming cooperative oligomeric complexes on RNA substrates
[70,71]. HuR is principally nuclear, but stabilizes mRNA targets
when translocated to the cytoplasm [72]. The nuclear-cytoplas-
mic distribution of HuR is regulated by several intracellular
signaling pathways [73–75], including some associated with
mitogenic stimulation like selected isoforms of protein kinase C
[76,77] and the p38
MAPK pathway [78].
While our study demonstrates that post-induction destabili-
zation of PIM1 mRNA is associated with accumulation of TTP
levels, additional mechanisms may ‘‘fine-tune’’ temporal control
of gene activation through ARE-directed mRNA decay. First,
TTP itself may be regulated by phosphorylation via the
p38
MAPK-activated kinase MK2 [79], which promotes associa-
tion with cytoplasmic 14-3-3 proteins [80,81]. Second, TTP
expression is also temporally regulated, as indicated by
decreases in TTP protein levels 12 hours after stimulation of
HeLa cells with serum+TPA, or as early as 4 to 6 hours post-
stimulation in MDA-MB-231 cells (Figure 3B). It is likely that
several mechanisms contribute to post-induction suppression of
TTP levels, including protein turnover through proteasome
pathway [79,82], and ARE-directed destabilization of TTP
mRNA, which can be enhanced by TTP in a negative feedback
loop [83]. Third, gene regulatory effects of transiently increasing
T T Pl e v e l sa r eu n l i k e l yt ob el imited solely to mRNA decay,
since many mRNAs containing ARE motifs encode transcrip-
tional regulators [84]. By destabilizing some of these transcripts,
TTP can suppress levels of their encoded protein products, and
hence the ability of these factors to regulate transcription of
their target genes. Finally, TTP i so n eo fal a r g ep o p u l a t i o no f
cellular factors competing for many ARE-containing transcripts
(described above). Gene-specific consequences of mitogenic or
other stimuli on post-transcriptional control of gene expression
will thus be influenced by competition or cooperation among
diverse ARE-binding proteins, among which many may be
subject to stimulus-dependent regulation of expression and/or
activity.
Supporting Information
Table S1 qRT-PCR primer sets used in this study.
Forward and reverse amplification primers are listed for all
mRNAs quantified by qRT-PCR. For mRNAs quantified using
multiplex qRT-PCR reactions, TaqMan probe sequences and
associated dye/quencher pairs are also included.
(DOC)
Acknowledgments
We thank Dr. Myriam Gorospe for helpful discussions and critical reading
of the manuscript.
Author Contributions
Conceived and designed the experiments: DBM SEB GMW. Performed
the experiments: DBM SEB EJF AK CRR TP JDR. Analyzed the data:
DBM SEB JDR GMW. Contributed reagents/materials/analysis tools:
JDR PJB BAH. Wrote the paper: DBM SEB GMW.
References
1. Bachmann M, Mo ¨ro ¨y T (2005) The serine/threonine kinase Pim-1.
Int J Biochem Cell Biol 37: 726–730.
2. Wan Z, Bhattacharya N, Weaver M, Petersen K, Meyer M, et al. (2001) Pim-1:
a serine/threonine kinase with a role in cell survival, proliferation, differentiation
and tumorigenesis. J Vet Sci 2: 167–179.
3. Mochizuki T, Kitanaka C, Noguchi K, Muramatsu T, Asai A, et al. (1999)
Physical and functional interactions between Pim-1 kinase and Cdc25A
phosphatase. J Biol Chem 274: 18659–18666.
4. Myer DL, Bahassi EM, Stambrook PJ (2005) The Plk3-Cdc25 circuit. Oncogene
24: 299–305.
Figure 7. Regulation of PIM1 mRNA induction by TTP following
mitogenic stimulation in MEF models. (A) Whole cell lysates were
prepared from MEFs derived from TTP knockout mice (TTP
2/2) and
wild-type littermates (TTP
+/+) following serum-starvation and stimula-
tion with serum+TPA as described in ‘‘Materials and Methods’’.
Expression of TTP and GAPDH were assessed at selected time points
by Western blot, with the positions of molecular weight markers (in
kDa) shown at left. (B) Total RNA was isolated from MEF cultures
stimulated as described in (A). Bars show the relative level of PIM1
mRNA in TTP
+/+ (solid bars) and TTP
2/2 (open bars) MEFs at indicated
times following mitogenic stimulation as determined by qRT-PCR and
normalized to GAPDH mRNA (mean 6 SD of quadruplicate qRT-PCR
reactions, *p,0.01 versus TTP
+/+). Independent replicate experiments
yielded similar results. (C) ActD was added to MEF cultures 2 hours after
stimulation with serum+TPA. PIM1 mRNA decay rates were then
measured as described in Figure 2, and yielded half-lives of
0.4260.11 h (n=4) for TTP
+/+ cells versus 1.5660.12 h (n=3) for
TTP
2/2 (p,0.0001 versus TTP
+/+).
doi:10.1371/journal.pone.0033194.g007
TTP Limits Mitogenic Induction of PIM1 Expression
PLoS ONE | www.plosone.org 10 March 2012 | Volume 7 | Issue 3 | e331945. Prives C, Gottifredi V (2008) The p21 and PCNA partnership: a new twist for an
old plot. Cell Cycle 7: 3840–3846.
6. Zhang Y, Wang Z, Magnuson NS (2007) Pim-1 kinase-dependent phosphor-
ylation of p21
Cip1/WAF1 regulates its stability and cellular localization in H1299
cells. Mol Cancer Res 5: 909–922.
7. Bachmann M, Hennemann H, Xing PX, Hoffmann I, Mo ¨ro ¨y T (2004) The
oncogenic serine/threonine kinase Pim-1 phosphorylates and inhibits the
activity of Cdc25C-associated kinase 1 (C-TAK1). J Biol Chem 279:
48319–48328.
8. Bhattacharya N, Wang Z, Davitt C, McKenzie IFC, Xing P, et al. (2002) Pim-1
associates with protein complexes necessary for mitosis. Chromosoma 111:
80–95.
9. Aho TLT, Sandholm J, Peltola KJ, Mankonen HP, Lilly M, et al. (2004) Pim-1
kinase promotes inactivation of the pro-apoptotic Bad protein by phosphory-
lating it on the Ser112 gatekeeper site. FEBS Lett 571: 43–49.
10. Gu JJ, Wang Z, Reeves R, Magnuson NS (2009) PIM1 phosphorylates and
negatively regulates ASK1-mediated apoptosis. Oncogene 28: 4261–4271.
11. Morishita D, Katayama R, Sekimizu K, Tsuruo T, Fujita N (2008) Pim kinases
promote cell cycle progression by phosphorylating and down-regulating p27
Kip1
at the transcriptional and posttranscriptional levels. Cancer Res 68: 5076–5085.
12. Peltola KJ, Paukku K, Aho TLT, Ruuska M, Silvennoinen O, et al. (2004) Pim-
1 kinase inhibits STAT5-dependent transcription via its interactions with
SOCS1 and SOCS3. Blood 103: 3744–3750.
13. Chen XP, Losman JA, Cowan S, Donahue E, Fay S, et al. (2002) Pim serine/
threonine kinases regulate the stability of Socs-1 protein. Proc Natl Acad Sci
USA 99: 2175–2180.
14. Leverson JD, Koskinen PJ, Orrico FC, Rainio EM, Jalkanen KJ, et al. (1998)
Pim-1 kinase and p100 cooperate to enhance c-Myb activity. Mol Cell 2:
417–425.
15. Zippo A, De Robertis A, Serafini R, Oliviero S (2007) PIM1-dependent
phosphorylation of histone H3 at serine 10 is required for MYC-dependent
transcriptional activation and oncogenic transformation. Nat Cell Biol 9:
932–944.
16. Wang J, Kim J, Roh M, Franco OE, Hayward SW, et al. (2010) Pim1 kinase
synergizes with c-MYC to induce advanced prostate carcinoma. Oncogene 29:
2477–2487.
17. van Lohuizen M, Verbeek S, Krimpenfort P, Domen J, Saris C, et al. (1989)
Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with
c-myc and N-myc in murine leukemia virus-induced tumors. Cell 56: 673–682.
18. Shah N, Pang B, Yeoh KG, Thorn S, Chen CS, et al. (2008) Potential roles for
the PIM1 kinase in human cancer - A molecular and therapeutic appraisal.
Eur J Cancer 44: 2144–2151.
19. Ionov Y, Le X, Tunquist BJ, Sweetenham J, Sachs T, et al. (2003) Pim-1 protein
kinase is nuclear in Burkitt’s lymphoma: nuclear localization is necessary for its
biologic effects. Anticancer Res 23: 167–178.
20. Warnecke-Eberz U, Bollschweiler E, Drebber U, Metzger R, Baldus SE, et al.
(2009) Prognostic impact of protein overexpression of the proto-oncogene PIM-1
in gastric cancer. Anticancer Res 29: 4451–4455.
21. Chen WW, Chan DC, Donald C, Lilly MB, Kraft AS (2005) Pim family kinases
enhance tumor growth of prostate cancer cells. Mol Cancer Res 3: 443–451.
22. Borg KE, Zhang M, Hegge D, Stephen RL, Buckley DJ, et al. (1999) Prolactin
regulation of pim-1 expression: positive and negative promoter elements.
Endocrinology 140: 5659–5668.
23. Jaster R, Tschirch E, Bittorf T, Brock J (1999) Interferon-alpha inhibits
proliferation of Ba/F3 cells by interfering with interleukin-3 action. Cell Signal
11: 769–775.
24. Rohwer F, Todd S, McGuire KL (1996) The effect of IL-2 treatment on
transcriptional attenuation in proto-oncogenes pim-1 and c-myb in human
thymic blast cells. J Immunol 157: 643–649.
25. Wingett D, Reeves R, Magnuson NS (1991) Stability changes in pim-1 proto-
oncogene mRNA after mitogen stimulation of normal lymphocytes. J Immunol
147: 3653–3659.
26. Hoover DS, Wingett DG, Zhang J, Reeves R, Magnuson NS (1997) Pim-1
protein expression is regulated by its 59-untranslated region and translation
initiation factor elF-4E. Cell Growth Differ 8: 1371–1380.
27. Mizuno K, Shirogane T, Shinohara A, Iwamatsu A, Hibi M, et al. (2001)
Regulation of Pim-1 by Hsp90. Biochem Biophys Res Commun 281: 663–669.
28. Ma J, Arnold HK, Lilly MB, Sears RC, Kraft AS (2007) Negative regulation of
Pim-1 protein kinase levels by the B56b subunit of PP2A. Oncogene 26:
5145–5153.
29. Sandler H, Stoecklin G (2008) Control of mRNA decay by phosphorylation of
tristetraprolin. Biochem Soc Trans 36: 491–496.
30. Baou M, Jewell A, Murphy JJ (2009) TIS11 family proteins and their roles in
posttranscriptional gene regulation. J Biomed Biotechnol 2009: 634520.
31. Stoecklin G, Tenebaum SA, Mayo T, Chittur SV, George AD, et al. (2008)
Genome-wide analysis identifies interleukin-10 mRNA as target of tristetrapro-
lin. J Biol Chem 283: 11689–11699.
32. Al-Souhibani N, Al-Ahmadi W, Hesketh JE, Blackshear PJ, Khabar KSA (2010)
The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs
involved in breast cancer-related processes. Oncogene 29: 4205–4215.
33. Lai WS, Parker JS, Grissom SF, Stumpo DJ, Blackshear PJ (2006) Novel mRNA
targets for tristetraprolin (TTP) identified by global analysis of stabilized
transcripts in TTP-deficient fibroblasts. Mol Cell Biol 26: 9196–9208.
34. Brennan SE, Kuwano Y, Alkharouf N, Blackshear PJ, Gorospe M, et al. (2009)
The mRNA-destabilizing protein tristetraprolin is suppressed in many cancers,
altering tumorigenic phenotypes and patient prognosis. Cancer Res 69:
5168–5176.
35. Suzuki A, Tsutomi Y, Akahane K, Araki T, Miura M (1998) Resistance to Fas-
mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator
p21
WAF1 and IAP gene family ILP. Oncogene 17: 931–939.
36. Ylsa RM, Wilson GM, Brewer G (2008) Assays of adenylate uridylate-rich
element-mediated mRNA decay in cells. Methods Enzymol 449: 47–71.
37. Fialcowitz EJ, Brewer BY, Keenan BP, Wilson GM (2005) A hairpin-like
structure within an AU-rich mRNA-destabilizing element regulates trans-factor
binding selectivity and mRNA decay kinetics. J Biol Chem 280: 22406–22417.
38. Wang W, Caldwell MC, Lin S, Furneaux H, Gorospe M (2000) HuR regulates
cyclin A and cyclin B1 mRNA stability during cell proliferation. EMBO J 19:
2340–2350.
39. Buckley AR, Buckley DJ, Leff MA, Hoover DS, Magnuson NS (1995) Rapid
induction of pim-1 expression by prolactin and interleukin-2 in rat Nb2
lymphoma cells. Endocrinology 136: 5252–5259.
40. Chen CYA, Shyu AB (1995) AU-rich elements: characterization and importance
in mRNA degradation. Trends Biochem Sci 20: 465–470.
41. Wilson GM, Brewer G (1999) The search for trans-acting factors controlling
messenger RNA decay. Prog Nucleic Acid Res Mol Biol 62: 257–291.
42. Barreau C, Paillard L, Osborne HB (2005) AU-rich elements and associated
factors: are there unifying principles? Nucleic Acids Res 33: 7138–7150.
43. Lai WS, Stumpo DJ, Blackshear PJ (1990) Rapid insulin-stimulated accumu-
lation of an mRNA encoding a proline-rich protein. J Biol Chem 265:
16556–16563.
44. DuBois RN, McLane MW, Ryder K, Lau LF, Nathans D (1990) A growth
factor-inducible nuclear protein with a novel cysteine/histidine repetitive
sequence. J Biol Chem 265: 19185–19191.
45. Brewer BY, Malicka J, Blackshear PJ, Wilson GM (2004) RNA sequence
elements required for high affinity binding by the zinc finger domain of
tristetraprolin: Conformational changes coupled to the bipartite nature of AU-
rich mRNA-destabilizing motifs. J Biol Chem 279: 27870–27877.
46. Carrick DM, Blackshear PJ (2008) Comparative expression of tristetraprolin
(TTP) family member transcripts in normal human tissues and cancer cell lines.
Arch Biochem Biophys 462: 278–285.
47. Lai WS, Kennington EA, Blackshear PJ (2002) Interactions of CCCH zinc
finger proteins with mRNA: Non-binding tristetraprolin mutants exert an
inhibitory effect on degradation of AU-rich element-containing mRNAs. J Biol
Chem 277: 9606–9613.
48. Blackshear PJ (2002) Tristetraprolin and other CCCH tandem zinc-finger
proteins in the regulation of mRNA turnover. Biochem Soc Trans 30: 945–952.
49. Franks TM, Lykke-Andersen J (2007) TTP and BRF proteins nucleate
processing body formation to silence mRNAs with AU-rich elements. Genes
Dev 21: 719–735.
50. Lykke-Andersen J, Wagner E (2005) Recruitment and activation of mRNA
decay enzymes by two ARE-mediated decay activation domains in the proteins
TTP and BRF-1. Genes Dev 19: 351–361.
51. Yu YP, Landsittel D, Jing L, Nelson J, Ren B, et al. (2004) Gene expression
alterations in prostate cancer predicting tumor aggression and preceding
development of malignancy. J Clin Oncol 22: 2790–2799.
52. Yu K, Ganesan K, Miller LD, Tan P (2006) A modular analysis of breast cancer
reveals a novel low-grade molecular signature in estrogen receptor-positive
tumors. Clin Cancer Res 12: 3288–3296.
53. Agnelli L, Bicciato S, Mattioli M, Fabris S, Intini D, et al. (2005) Molecular
classification of multiple myeloma: a distinct transcriptional profile characterizes
patients expressing CCND1 and negative for 14q32 translocations. J Clin Oncol
23: 7296–7306.
54. Essafi-Benkhadir K, Onesto C, Stebe E, Moroni C, Pages G (2007)
Tristetraprolin inhibits Ras-dependent tumor vascularization by inducing
vascular endothelial growth factor mRNA degradation. Mol Biol Cell 18:
4648–4658.
55. Phillips K, Kedersha N, Shen L, Blackshear PJ, Anderson P (2004) Arthritis
suppressor genes TIA-1 and TTP dampen the expression of tumor necrosis
factor a, cyclooxygenase 2, and inflammatory arthritis. Proc Natl Acad Sci U S A
101: 2011–2016.
56. Sawaoka H, Dixon DA, Oates JA, Boutand O (2003) Tristetraprolin binds to the
39-untranslated region of cyclooxygenase-2 mRNA. J Biol Chem 278:
13928–13935.
57. Hao S, Baltimore D (2009) The stability of mRNA influences the temporal order
of the induction of genes encoding inflammatory molecules. Nat Immunol 10:
281–288.
58. Mahtani KR, Brook M, Dean JLE, Sully G, Saklatvala J, et al. (2001) Mitogen-
activated protein kinase p38 controls the expression and posttranslational
modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA
stability. Mol Cell Biol 21: 6461–6469.
59. Lai WS, Thompson MJ, Blackshear PJ (1998) Characteristics of the intron
involvement in the mitogen-induced expression of Zfp-36. J Biol Chem 273:
506–517.
60. Krishnan N, Pan H, Buckley DJ, Buckley AR (2003) Prolactin-regulated pim-1
transcription: identification of critical promoter elements and Akt signaling.
Endocrine 20: 123–129.
TTP Limits Mitogenic Induction of PIM1 Expression
PLoS ONE | www.plosone.org 11 March 2012 | Volume 7 | Issue 3 | e3319461. Amit I, Citri A, Shay T, Lu Y, Katz M, et al. (2007) A module of negative
feedback regulators defines growth factor signaling. Nat Genet 39: 503–512.
62. Wagner BJ, DeMaria CT, Sun Y, Wilson GM, Brewer G (1998) Structure and
genomic organization of the human AUF1 gene: alternative pre-RNA splicing
generates four protein isoforms. Genomics 48: 195–202.
63. Zucconi BE, Ballin JD, Brewer BY, Ross CR, Huang J, et al. (2010)
Alternatively expressed domains of AU-rich element RNA-binding protein 1
(AUF1) regulate RNA-binding affinity, RNA-induced protein oligomerization,
and the local conformation of bound RNA ligands. J Biol Chem 285:
39127–39139.
64. Sarkar B, Xi Q, He C, Schneider RJ (2003) Selective degradation of AU-rich
mRNAs promoted by the p37 AUF1 protein isoform. Mol Cell Biol 23:
6685–6693.
65. Raineri I, Wegmueller D, Gross B, Certa U, Moroni C (2004) Roles of AUF1
isoforms, HuR and BRF1 in ARE-dependent mRNA turnover studied by RNA
interference. Nucleic Acids Res 32: 1279–1288.
66. Wilson GM, Lu J, Sutphen K, Sun Y, Huynh Y, et al. (2003) Regulation of
A+U-rich element-directed mRNA turnover involving reversible phosphoryla-
tion of AUF1. J Biol Chem 278: 33029–33038.
67. Lopez de Silanes I, Zhan M, Lal A, Yang X, Gorospe M (2004) Identification of
a target RNA motif for RNA-binding protein HuR. Proc Natl Acad Sci U S A
101: 2987–2992.
68. Fan XC, Steitz JA (1998) Overexpression of HuR, a nuclear-cytoplasmic
shuttling protein, increases the in vivo stability of ARE-containing mRNAs.
EMBO J 17: 3448–3460.
69. Peng SSY, Chen CYA, Xu N, Shyu AB (1998) RNA stabilization by the AU-
rich element binding protein, HuR, an ELAV protein. EMBO J 17: 3461–3470.
70. Fialcowitz-White EJ, Brewer BY, Ballin JD, Willis CD, Toth EA, et al. (2007)
Specific protein domains mediate cooperative assembly of HuR oligomers on
AU-rich mRNA-destabilizing sequences. J Biol Chem 282: 20948–20959.
71. Toba G, White K (2008) The third RNA recognition motif of Drosophila ELAV
protein has a role in multimerization. Nucleic Acids Res 36: 1390–1399.
72. Doller A, Pfeilschifter J, Eberhardt W (2008) Signalling pathways regulating
nucleo-cytoplasmic shuttling of the mRNA-binding protein HuR. Cell Signal 20:
2165–2173.
73. Zou T, Mazan-Mamczarz K, Rao JN, Liu L, Marasa BS, et al. (2006)
Polyamine depletion increases cytoplasmic levels of RNA-binding protein HuR
leading to stabilization of nucleophosmin and p53 mRNAs. J Biol Chem 281:
19387–19394.
74. Kim HH, Abdelmohsen K, Lal A, Pullmann Jr. R, Yang X, et al. (2008) Nuclear
HuR accumulation through phosphorylation by Cdk1. Genes Dev 22:
1804–1815.
75. Wang W, Yang X, Kawai T, Lopez de Silanes I, Mazan-Mamczarz K, et al.
(2004) AMP-activated protein kinase-regulated phosphorylation and acetylation
of importin a1: Involvement in the nuclear import of RNA-binding protein
HuR. J Biol Chem 279: 48376–48388.
76. Doller A, Huwiler A, Muller R, Radeke HH, Pfeilschifter J, et al. (2007) Protein
kinase Ca-dependent phosphorylation of the mRNA-stabilizing factor HuR:
Implications for posttranscriptional regulation of cyclooxygenase-2. Mol Biol
Cell 18: 2137–2148.
77. Doller A, Akool E, Huwiler A, Muller R, Radeke HH, et al. (2008)
Posttranslational modification of the AU-rich element binding protein HuR
by protein kinase Cd elicits angiotensin II-induced stabilization and nuclear
export of cyclooxygenase 2 mRNA. Mol Cell Biol 28: 2608–2625.
78. Tran H, Maurer F, Nagamine Y (2003) Stabilization of urokinase and urokinase
receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by
activated mitogen-activated protein kinase-activated protein kinase 2. Mol Cell
Biol 23: 7177–7188.
79. Hitti E, Iakovleva T, Brook M, Deppenmeier S, Gruber AD, et al. (2006)
Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor
necrosis factor mRNA stability and translation mainly by altering tristetraprolin
expression, stability, and binding to adenine/uridine-rich element. Mol Cell Biol
26: 2399–2407.
80. Stoecklin G, Stubbs T, Kedersha N, Wax S, Rigby WFC, et al. (2004) MK2-
induced tristetraprolin:14-3-3 complexes prevent stress granule association and
ARE-mRNA decay. EMBO J 23: 1313–1324.
81. Sun L, Stoecklin G, Van Way S, Hinkovska-Galcheva V, Guo RF, et al. (2007)
Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephos-
phorylation by protein phosphatase 2A and stabilizes tumor necrosis factor-a
mRNA. J Biol Chem 282: 3766–3777.
82. Brook M, Tchen CR, Santalucia T, McIlrath J, Arthur JS, et al. (2006)
Posttranslational regulation of tristetraprolin subcellular localization and protein
stability by p38 mitogen-activated protein kinase and extracellular signal-
regulated kinase pathways. Mol Cell Biol 26: 2408–2418.
83. Tchen CR, Brook M, Saklatvala J, Clark AR (2004) The stability of
tristetraprolin mRNA is regulated by mitogen-activated protein kinase p38
and by tristetraprolin itself. J Biol Chem 279: 32393–32400.
84. Bakheet T, Williams BRG, Khabar KSA (2006) ARED 3.0: the large and
diverse AU-rich transcriptome. Nucleic Acids Res 34: D111–D114.
TTP Limits Mitogenic Induction of PIM1 Expression
PLoS ONE | www.plosone.org 12 March 2012 | Volume 7 | Issue 3 | e33194